{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:04:17Z","timestamp":1780668257100,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012621","name":"NIHR University College London Hospitals Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC4\/III\/CC"],"award-info":[{"award-number":["BRC4\/III\/CC"]}],"id":[{"id":"10.13039\/501100012621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC815\/HI\/JM\/101,440"],"award-info":[{"award-number":["BRC815\/HI\/JM\/101,440"]}],"id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012041","name":"Versus Arthritis","doi-asserted-by":"publisher","award":["22,856"],"award-info":[{"award-number":["22,856"]}],"id":[{"id":"10.13039\/501100012041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013867\/1"],"award-info":[{"award-number":["MR\/N013867\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006662","name":"National Institute on Handicapped Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijid.2025.108119","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:23:06Z","timestamp":1760538186000},"page":"108119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention"],"prefix":"10.1016","volume":"161","author":[{"given":"Alexandra E.","family":"Oppong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Coelewij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George A.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Liddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam F.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coziana","family":"Ciurtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Venkatachalam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel S.","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ardern-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Duncombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2389-3396","authenticated-orcid":false,"given":"Elizabeth C.","family":"Jury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.108119_bib0001","unstructured":"WHO COVID-19 dashboard, Geneva: World Health Organization, 2020."},{"key":"10.1016\/j.ijid.2025.108119_bib0002","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108119_bib0003","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.7861\/clinmed.2021-0053","article-title":"Secondary haemophagocytic lymphohistiocytosis in hospitalized COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality","volume":"21","author":"Ardern-Jones","year":"2021","journal-title":"Clin Med (L)"},{"key":"10.1016\/j.ijid.2025.108119_bib0004","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/annrheumdis-2020-218323","article-title":"Preliminary predictive criteria for COVID-19 cytokine storm","volume":"80","author":"Roberto","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2025.108119_bib0005","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(20)30275-7","article-title":"COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study","volume":"2","author":"Manson","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2025.108119_bib0006","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S2665-9913(20)30343-X","article-title":"Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study","volume":"2","author":"Webb","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2025.108119_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280079","article-title":"A hyperinflammation clinical risk tool, HI5-NEWS2, stratifies hospitalized COVID-19 patients to associate risk of death and effect of early dexamethasone in an observational cohort","volume":"18","author":"Ardern-Jones","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.108119_bib0008","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2025.108119_bib0009","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108119_bib0010","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2665-9913(21)00216-2","article-title":"Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis","volume":"3","author":"Kyriazopoulou","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2025.108119_bib0011","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","article-title":"Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial","volume":"27","author":"Kyriazopoulou","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.ijid.2025.108119_bib0012","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(22)01109-6","article-title":"Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis","volume":"400","author":"Abani","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108119_bib0013","doi-asserted-by":"crossref","first-page":"73","DOI":"10.12688\/f1000research.45046.1","article-title":"Optimal use of tocilizumab for severe and critical COVID-19: a systematic review and meta-analysis","volume":"10","author":"Nugroho","year":"2021","journal-title":"F1000Res"},{"key":"10.1016\/j.ijid.2025.108119_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.572635","article-title":"A \"window of therapeutic opportunity\" for anti-cytokine therapy in patients with coronavirus disease 2019","volume":"11","author":"De Stefano","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijid.2025.108119_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: a free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2025.108119_bib0016","article-title":"AutoScore: a machine learning-based automatic clinical score generator and its application to mortality prediction using electronic health records","volume":"8","author":"Xie","year":"2020","journal-title":"JMIR Med Inf"},{"key":"10.1016\/j.ijid.2025.108119_bib0017","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(20)30691-7","article-title":"Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?","volume":"395","author":"Ritchie","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2025.108119_bib0018","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1164\/rccm.201101-0135OC","article-title":"Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome","volume":"183","author":"Brun-Buisson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2025.108119_bib0019","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/myc.13256","article-title":"The double-edged sword of systemic corticosteroid therapy in viral pneumonia: a case report and comparative review of influenza-associated mucormycosis versus COVID-19 associated mucormycosis","volume":"64","author":"Ahmadikia","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.ijid.2025.108119_bib0020","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.dsx.2021.03.022","article-title":"Predictors of new-onset diabetic ketoacidosis in patients with moderate to severe COVID-19 receiving parenteral glucocorticoids: a prospective single-centre study among Indian type 2 diabetes patients","volume":"15","author":"Mondal","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.ijid.2025.108119_bib0021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13098-020-00583-7","article-title":"Dexamethasone in the era of COVID-19: friend or foe? An essay on the effects of dexamethasone and the potential risks of its inadvertent use in patients with diabetes","volume":"12","author":"Alessi","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.ijid.2025.108119_bib0022","article-title":"Systemic corticosteroids for management of COVID-19: saving lives or causing harm?","volume":"35","author":"FakhriRavari","year":"2021","journal-title":"Int J Immunopathol Pharmacol Engl"},{"key":"10.1016\/j.ijid.2025.108119_bib0023","doi-asserted-by":"crossref","first-page":"e437","DOI":"10.1016\/S2665-9913(20)30121-1","article-title":"Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia","volume":"2","author":"McGonagle","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.ijid.2025.108119_bib0024","article-title":"Predictive value of D-dimer\/albumin ratio and fibrinogen\/albumin ratio for in-hospital mortality in patients with COVID-19","volume":"75","author":"K\u00fc\u00e7\u00fckceran","year":"2021","journal-title":"Int, J Clin, Pr"},{"key":"10.1016\/j.ijid.2025.108119_bib0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.dld.2020.08.004","article-title":"Systemic inflammation as fuel for acute liver injury in COVID-19","volume":"53","author":"Effenberger","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ijid.2025.108119_bib0026","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12016-022-08921-5","article-title":"Risk and protective factors for COVID-19 morbidity, severity, and mortality","volume":"64","author":"Zhang","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ijid.2025.108119_bib0027","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/joim.13199","article-title":"Insights into disparities observed with COVID-19","volume":"289","author":"Carethers","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijid.2025.108119_bib0028","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jamaneurol.2021.0688","article-title":"Outcomes and risk factors associated With SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis","volume":"78","author":"Salter","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ijid.2025.108119_bib0029","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2020.6548","article-title":"COVID-19 and African Americans","volume":"323","author":"Yancy","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2025.108119_bib0030","doi-asserted-by":"crossref","first-page":"e695","DOI":"10.1093\/cid\/ciaa1419","article-title":"Risk factors for coronavirus disease 2019 (COVID-19)\u2013associated hospitalization: COVID-19\u2013associated hospitalization surveillance network and behavioral risk factor surveillance system","volume":"72","author":"Ko","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.108119_bib0031","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae294","article-title":"Obesity and age are transmission risk factors for SARS-CoV-2 infection among exposed individuals","volume":"3","author":"Matamalas","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.ijid.2025.108119_bib0032","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/all.14657","article-title":"Risk factors for severe and critically ill COVID-19 patients: a review","volume":"76","author":"Gao","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.ijid.2025.108119_bib0033","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","article-title":"Symptoms and risk factors for long COVID in non-hospitalized adults","volume":"28","author":"Subramanian","year":"2022","journal-title":"Nat, Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971225003418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:02:11Z","timestamp":1780664531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971225003418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":33,"alternative-id":["S1201971225003418"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108119","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simple hyperinflammation scores predict mortality in hospitalized patients with COVID-19 and offer a personalized medicine approach to dexamethasone intervention","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.108119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108119"}}